Clinical Trial Update: Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating the safety, tolerability, and immunogenicity of a multivalent Group B Streptococcus vaccine in healthy nonpregnant w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection

Drugs mentioned

• Pfizer multivalent Group B Streptococcus vaccine (Group B Streptococcus vaccine)

Snippet

Sponsor: Pfizer | Conditions: Group B Streptococcus Infections | Phase 2 | Status: COMPLETED | Results posted: 2025-08-05